Responding to Activist Investors, Companies Give Poison Pill More Punch

Last week, we noted a strongly worded opinion by NY district judge Lewis Kaplan that reprimanded two hedge-funds for the way they used derivatives to obscure their takeover plans for railroad CSX. Today, the WSJ’s Mara Lemos-Stein reports on a novel move by companies to take the matter into their own hands by “redefining stock [...]